Mexico, Argentina aim to roll out vaccine early next year

0
106

[ad_1]

coronavirus
Credit: CC0 Public Domain

Mexico and Argentina aim to have a coronavirus vaccine obtainable for Latin America early next year beneath a manufacturing settlement with medication big AstraZeneca, the Mexican authorities mentioned Thursday.

The vaccine, being developed in collaboration with the University of Oxford, is without doubt one of the most promising of dozens that researchers all over the world are racing to show protected and environment friendly.

The purpose is to “start manufacturing to have the vaccine in the first quarter of next year,” Mexican President Andres Manuel Lopez Obrador advised a information convention.

He mentioned entry to the vaccine could be “universal and free” in Mexico, which has registered practically 55,000 coronavirus deaths—the third-highest toll on the earth.

Production might be funded by the muse of Mexican mogul Carlos Slim.

AstraZeneca’s Mexico consultant Silvia Varela mentioned the lively element could be made in Argentina and despatched to Mexico the place the vaccine might be accomplished for export across the area.

Brazil, which has recorded greater than 100,000 coronavirus deaths, has a separate settlement with the British-Swedish prescription drugs firm.

Mexico mentioned it had requested Russia for extra on its new coronavirus , dubbed “Sputnik V,” which Moscow hailed this week was the primary to be permitted providing “sustainable immunity.”


Follow the latest news on the coronavirus (COVID-19) outbreak


© 2020 AFP

Citation:
Mexico, Argentina aim to roll out vaccine early next year (2020, August 13)
retrieved 13 August 2020
from https://medicalxpress.com/information/2020-08-mexico-argentina-aim-vaccine-early.html

This doc is topic to copyright. Apart from any honest dealing for the aim of personal research or analysis, no
half could also be reproduced with out the written permission. The content material is supplied for info functions solely.



[ad_2]

Source link

Leave a Reply